1385841-62-2Relevant academic research and scientific papers
Investigation on the 1,6-naphthyridine motif: Discovery and SAR study of 1H-imidazo[4,5-h][1,6]naphthyridin-2(3H)-one-based c-Met kinase inhibitors
Wang, Yong,Xu, Zhong-Liang,Ai, Jing,Peng, Xia,Lin, Jian-Ping,Ji, Yin-Chun,Geng, Mei-Yu,Long, Ya-Qiu
, p. 1545 - 1562 (2013/05/09)
The 1,6-naphthyridine motif is a multivalent scaffold in medicinal chemistry presenting various bioactivities when properly substituted. By incorporating a cyclic urea pharmacophore into the 1,6-naphthyridine framework through conformationally constraining the 7,8-positions, the resulting 1H-imidazo[4,5-h][1,6]naphthyridin-2(3H)-one was identified as a new class of c-Met kinase inhibitor. A comprehensive SAR study indicated that an N-1 alkyl substituent bearing a terminal free amino group, a hydrophobic substituted benzyl group at the N-3 position and the tricyclic core were essential for retaining effective Met inhibition of the 1H-imidazo[4,5-h][1,6]naphthyridin- 2(3H)-one chemotype. Further introduction of a 4′-carboxamide phenoxy group at the C-5 position significantly improved the potency. The best c-Met kinase inhibitory activity was exemplified by 2t with an IC50 = 2.6 μM, which also displayed effective inhibition against TPR-Met phosphorylation and the proliferation of the BaF3-TPR-Met cells at low micromolar concentrations.
Repositioning HIV-1 integrase inhibitors for cancer therapeutics: 1,6-naphthyridine-7-carboxamide as a promising scaffold with drug-like properties
Zeng, Li-Fan,Wang, Yong,Kazemi, Roza,Xu, Shili,Xu, Zhong-Liang,Sanchez, Tino W.,Yang, Liu-Meng,Debnath, Bikash,Odde, Srinivas,Xie, Hua,Zheng, Yong-Tang,Ding, Jian,Neamati, Nouri,Long, Ya-Qiu
, p. 9492 - 9509 (2013/01/16)
Among a large number of HIV-1 integrase (IN) inhibitors, the 8-hydroxy-[1,6]naphthyridines (i.e., L-870,810) were one of the promising class of antiretroviral drugs developed by Merck Laboratories. In spite of its remarkable potency and efficacy, unfortun
